HAPPE Spine
PrivateLast Round
VC Round
Nov 13, 2025
Total Funding Raised
$7.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
HAPPE Spine operates in Healthcare & Life Sciences and is based in Grand Rapids, Michigan. Its latest recorded funding round was a VC Round in November 2025.
HAPPE Spine is a medical devices company that develops and commercializes orthopedic and spinal implants utilizing a patented material platform.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HAPPE Spine Comparables
Compare HAPPE Spine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Curiteva, Inc. | 89% | |
| Cutting Edge Spine | 88% | |
| Zavation Medical Products | 82% |
For institutional investors. Book with your work email.
HAPPE Spine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 13, 2025 | ||||
| Series A Extension | Sep 27, 2023 | ||||
| Series A | Nov 8, 2021 | ||||
| Seed | Apr 11, 2019 | ||||
| Seed | Jul 19, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
HAPPE Spine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | VC Round |
| VisionTech Partners | VC Round |
| Genesis Innovation Group | Seed, Series A, Series A Extension, VC Round |
| cultivate(MD) Capital Fund II, LP | Seed |
| Michigan Rise | VC Round |
| cultivate(MD) | Seed, Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 13, 2025
Funded by Genesis Innovation Group, MedTech Innovator, and Michigan Rise.
- Jun 4, 2025
Grew 60% QoQ from 5 to 8 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_awardSep 2, 2026
Happe Spine, creator of the Hydroxyapatite Porous PEEK device and process, receives the Orthopedics This Week Spine Technology of the Year Award.
For institutional investors. Book with your work email.
HAPPE Spine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HAPPE Spine's valuation, stock price, and market status.
Is HAPPE Spine a public or private company?
HAPPE Spine is a private company.
What is the current stock price of HAPPE Spine?
HAPPE Spine is a private company, so its shares have no public market price. Caplight tracks HAPPE Spine's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HAPPE Spine worth (valuation)?
Valuation information for HAPPE Spine is not publicly available.
Can I buy HAPPE Spine stock?
HAPPE Spine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HAPPE Spine's last funding round?
HAPPE Spine's most recent funding round was VC Round on November 13, 2025.
Who are the main investors in HAPPE Spine?
Key investors in HAPPE Spine include MedTech Innovator, VisionTech Partners, Genesis Innovation Group, cultivate(MD) Capital Fund II, LP, Michigan Rise.
Will HAPPE Spine IPO soon?
No public IPO plans have been announced for HAPPE Spine.
How can I track HAPPE Spine secondary market activity?
Caplight tracks bids, offers, and trades in HAPPE Spine's shares on secondary markets.